ITC To Investigate Hemophilia Drug Imports
The U.S. International Trade Commission said Monday it will investigate claims that Danish pharmaceutical company Novo Nordisk A/S plans to import into the U.S. certain drugs for treating hemophilia that infringe...To view the full article, register now.
Already a subscriber? Click here to view full article